BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Loading...
Loading...

revlimid waldenstrom s 2008 Pages on BioPortfolio:

BioPortfolio - revlimid waldenstrom s 2008
revlimid waldenstrom s 2008 - BioPortfolio. ... 634 Current Opinion in Investigational Drugs 2008 Vol 9 No 6 inhibition exceeded . ...
http://www.bioportfolio.com/search/revlimid_waldenstrom_s_20...

BioPortfolio - Waldenstrom Macroglobulinemia
5th November, 2008, Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber ... Recent Search Terms used to find this page: waldenstrom october 2008 ...
http://www.bioportfolio.com/indepth/Waldenstrom_Macroglobuli...

BioPortfolio - TLR 3 agonists wikipedia
revlimid waldenstrom - BioPortfolio. ... TLR 3 agonists wikipedia | waldenstrom | waldenstrom | waldenstrom 2008 | revlimid waldenstrom . ...
http://www.bioportfolio.com/search/TLR_3_agonists_wikipedia....

BioPortfolio - Monoclonal Gammopathy of Undetermined Significance ...
lymphoma/Waldenstrom macroglobulinemia patients: a population-based study in Sweden. ... 2008 Sep 2;105(35):12885-90. Epub 2008 Aug 26. (DOI Direct Link) ...
http://www.bioportfolio.com/indepth/Monoclonal_Gammopathy_of...

BioPortfolio - Dana Corporation - Profile
2008 Nov 3. (DOI Direct Link). • Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia. Waldenstrom Macroglobulinemia (WM) ...
http://www.bioportfolio.com/biocorporate/3246-Dana+Corporati...

BioPortfolio - dana-farber cancer institute - Profile
Waldenstrom Macroglobulinemia (WM) is an incurable low-grade lymphoma...5th November, 2008. Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber ...
http://www.bioportfolio.com/biocorporate/3248-dana-farber+ca...

Results from other life science and pharmaceutical sites:

BioPortfolio - Waldenstrom Macroglobulinemia
5th November, 2008, Bing Center for Waldenstrom's Macroglobulinemia, Dana-Farber ... Recent Search Terms used to find this page: waldenstrom october 2008 ...
http://www.bioportfolio.com/indepth/Waldenstrom_Macroglobuli...

Targeted therapies in Waldenström macroglobulinemia
of familial Waldenströms macroglobulinemia. Ann Oncol (2006). 17(3):488-494. ... This abstract reviews the promising efficacy of lenalidomide (revlimid) in
...
http://www.biomedcentral.com/content/pdf/cd-910549.pdf...

Leukemia - Treatment of plasma cell dyscrasias with lenalidomide
Reece DE, Masih-Khan E, Chen C, Wang L, Dean S, Kukreti V et al. Use of lenalidomide (Revlimid(R) +/- corticosteroids in relapsed/refractory multiple
...
http://www.nature.com/leu/journal/v22/n7/full/leu2008123a.ht...

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomi...[Blood. 2008 ...
2008 Feb 1;111(3):1101-9. Epub 2007 Nov 7. Click here to read ... and dexamethasone) for the treatment of myeloma and Waldenström's macroglobulinemia.
...
http://www.ncbi.nlm.nih.gov/pubmed/17989313...

{2}'s Clinical Data On REVIMID(TM) In Multiple Myeloma And ...
Celgene's (CELG) Clinical Data On REVIMID(TM) In Multiple Myeloma And Myelodysplastic Syndromes To Be Presented At The American Society of Hematology
(ASH) ...
http://www.biospace.com/news_story.aspx?NewsEntityId=1453742...

[The treatment of Waldenström macroglobulinemia and the therapy of ...
2008 Jan;54(1):68-83. [The treatment of Waldenström macroglobulinemia and ... this disease have been tested (bortezomib, thalidomid, revlimid and others). ...
http://www.ncbi.nlm.nih.gov/pubmed/18390120...

News Release - Drug Combination Effective Against Multiple Myeloma ...
... with myeloma received either a combination of lenalidomide (Revlimid) and the ... Johns Hopkins; S. Vincent Rajkumar, M.D., Mayo Clinic Cancer Center; ...
http://www.mdanderson.org/diseases/myeloma/display.cfm?id=8f...

ACS :: Biological Therapy or Immunotherapy
Lenalidomide (Revlimid) is a newer drug that is similar to thalidomide. ... some patients who have non-Hodgkin lymphoma or Waldenstrom macroglobulinemia. ...
http://www.cancer.org/docroot/CRI/content/CRI_2_4_4x_Biologi...

Leukemia Department - Clinical Trials - M. D. Anderson Cancer Center
Rituximab + Alemtuzumab (2006-0767); Revlimid (2007-0213). Prior Therapy ... PR- 1 Vaccine + Gleevec (2006-0360); Dasatinib + Ipilimumab (2008-0157) ...
http://www.mdanderson.org/departments/leukemia/dIndex.cfm?pn...

Weill Cornell Comprehensive Cancer Care
Cannot have MGUS or Waldenstrom's disease ... Lenalidomide (Revlimid®) will be given orally at a dose of 25 mg daily beginning on day 1 and ending on day 21
...
http://www.med.cornell.edu/cancercare/trials/lymphoma/multip...

Google Custom Search

Search
  

  Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2008 - BioPortfolio Limited.